STAT+: Helus’ psychedelic drug improved depression in study but faces safety questions
A psychedelic drug from Helus Pharma improved depression in a study, but is facing safety questions with a number of serious adverse events reported.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.